Relationship between chemoresistance of lung tumours and cigarette smoking.

por Volm, M., Samsel, B., Mattern, J.
Publicado 1990

Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.

por Volm, M., Mattern, J., Samsel, B.
Publicado 1991

Occurrence of a multidrug-resistant phenotype in human lung xenografts.

por Mattern, J., Bak, M., Volm, M.
Publicado 1987

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.

por Mattern, J., Koomägi, R., Volm, M.
Publicado 1996

Protein expression profiles indicative for drug resistance of non-small cell lung cancer

por Volm, M, Koomägi, R, Mattern, J, Efferth, T
Publicado 2002

Growth of human bronchial carcinomas in nude mice.

por Mattern, J., Jäger, S., Sonka, J., Wayss, K., Volm, M.
Publicado 1985

Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.

por Volm, M., Drings, P., Hahn, E. W., Mattern, J.
Publicado 1988

Development of drug resistance in a human epidermoid lung carcinoma xenograft line.

por Mattern, J., Bak, M., Hoever, K. H., Volm, M.
Publicado 1988

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.

por Volm, M., Koomägi, R., Mattern, J., Stammler, G.
Publicado 1997

P-glycoprotein expression in treated and untreated human breast cancer.

por Schneider, J., Bak, M., Efferth, T., Kaufmann, M., Mattern, J., Volm, M.
Publicado 1989

Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells

por Ucur, E, Mattern, J, Wenger, T, Okouoyo, S, Schroth, A, Debatin, K-M, Herr, I
Publicado 2003

Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo

por Gassler, N, Zhang, C, Wenger, T, Schnabel, P A, Dienemann, H, Debatin, K-M, Mattern, J, Herr, I
Publicado 2005

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

por Hage, C, Rausch, V, Giese, N, Giese, T, Schönsiegel, F, Labsch, S, Nwaeburu, C, Mattern, J, Gladkich, J, Herr, I
Publicado 2013

Enrichment of c-Met(+) tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib

por Liu, L, Aleksandrowicz, E, Fan, P, Schönsiegel, F, Zhang, Y, Sähr, H, Gladkich, J, Mattern, J, Depeweg, D, Lehner, B, Fellenberg, J, Herr, I
Publicado 2014

Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy

por Fan, P, Zhang, Y, Liu, L, Zhao, Z, Yin, Y, Xiao, X, Bauer, N, Gladkich, J, Mattern, J, Gao, C, Schemmer, P, Gross, W, Herr, I
Publicado 2016

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

por Beckermann, B M, Kallifatidis, G, Groth, A, Frommhold, D, Apel, A, Mattern, J, Salnikov, A V, Moldenhauer, G, Wagner, W, Diehlmann, A, Saffrich, R, Schubert, M, Ho, A D, Giese, N, Büchler, M W, Friess, H, Büchler, P, Herr, I
Publicado 2008